Santa Clara, Calif. -- Affymetrix, a Santa Clara-based developer of microarray technology used to analyze complex genetic information, said that it will pay $73 million in cash to acquire Fremont-based Panomics, a maker of assay products for a variety of genetic, protein and cellular analysis applications. Affymetrix said that the deal, expected to close by the end of this year, will strengthen its position in the high-growth validation and routine-testing market segments. "As one company, we will be able to serve a much larger customer base around the world with a broader product portfolio," said Kevin King, the president of Affymetrix.
http://www.panomics.com
http://www.affymetrix.com
http://www.businesswire.com/news/home/20081111005912/en